Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma
Status:
Recruiting
Trial end date:
2023-08-31
Target enrollment:
Participant gender:
Summary
To explore the treatment efficacy of megestrol acetate plus rosuvastatin in patients with
early endometrial carcinoma (EEC) seeking for conservative treatment.